Q&A with Dr. Timothy Hohman: Studying the Genetics Behind Resilience in Alzheimer’s Disease
Dr. Timothy Hohman discusses his Alzheimer's disease research and how it has evolved since receiving a PhRMA Foundation award.
BlogDr. Timothy Hohman discusses his Alzheimer's disease research and how it has evolved since receiving a PhRMA Foundation award.
BlogThe PhMRA Foundation builds academic capacity in biopharma to examine the knowledge gaps that hold back innovation.
BlogDr. Nir Pillar of the University of California, Los Angeles, seeks to combine novel microscopy methodologies and artificial intelligence to improve detection of systemic amyloidosis.
BlogAs researchers develop new approaches for value assessment, we must ensure the patient voice remains at the forefront.
BlogDr. Paul Campbell, who received a Foundation Research Starter Grant in 2016, specializes in cancer signaling, with a goal to uncover novel targets for therapeutic development.
BlogThe PhRMA Foundation awarded $25,000 Challenge Awards to the authors of three papers exploring challenges facing CMS in Medicare drug price negotiation.
Press ReleasesThe authors argue that it is important to consider the trade-offs of social distancing measures to reasonably capture all relevant benefits and costs.
BlogMeaningful patient engagement is critical to overcome the challenges in making value assessment more patient-centric.
BlogA recent analysis shows that traditional value assessment models only include about 25% of the value elements that patients care about.
BlogPhRMA Foundation President Dr. Amy Miller discusses her health struggles as a rare disease patient and how the Inflation Reduction Act may curb industry investment in rare diseases like hers.
Blog